GlassScriptPhysician profile
Arthur Boltz
NPI 1215281118
$1,286.48
in general payments reported to CMS, 2019-2025
27 companies · $14.07 in 2025
The $14.07 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $448 · 2022: $278 · 2023: $419 · 2024: $128 · 2025: $14.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $612.27 | 2021-2024 | |
| Lilly USA, LLC | $103.30 | 2023-2024 | Mounjaro, Zepbound |
| Novo Nordisk INC | $73.16 | 2021-2023 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $66.85 | 2021-2023 | Spravato |
| Daiichi Sankyo INC. | $46.68 | 2021 | |
| Sanofi Pasteur INC. | $44.45 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $25.33 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $23.37 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $21.50 | 2021 | |
| Boston Scientific Corporation | $18.50 | 2021 | |
| Edwards Lifesciences Corporation | $18.30 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Ultragenyx Pharmaceutical INC. | $17.72 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.68 | 2022 | |
| Exact Sciences Corporation | $16.50 | 2023 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $15.38 | 2023 | Seglentis, Livalo |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.17 | 2021 | |
| Amgen INC. | $15.11 | 2024 | Otezla, Repatha |
| Biohaven Pharmaceutical Holding Company LTD. | $14.87 | 2022 | |
| Merck Sharp & Dohme LLC | $14.83 | 2022 | |
| Seqirus USA INC | $14.46 | 2022 | |
| Currax Pharmaceuticals LLC | $14.15 | 2021 | |
| Inspire Medical Systems, INC. | $14.07 | 2025 | Inspire |
| Cranial Technologies, INC | $13.40 | 2021 | |
| Organon LLC | $13.07 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.69 | 2021 | |
| Collaborative Care Diagnostics, LLC | $12.07 | 2023 | |
| Antares Pharma, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Boltz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.